Literature DB >> 15181486

Symptom development and timing of menarche: a longitudinal study.

Bassam Michel El-Khouri1, Christin Mellner.   

Abstract

Self-reported somatic complaints among females were studied cross sectionally at age 15 and 43, an longitudinally between these two ages. Specifically, the relationship between symptom development and timing of menarche was considered. The sample consisted of 477 females representing the general Swedish population. All the included symptoms were significantly related to each other at both ages. There was also longitudinal correlational stability for all the studied symptoms. Moreover, symptoms at age 15 were associated with early menarcheal timing. Pattern analyses of the studied symptoms were conducted with roots in person-oriented methodology. These results revealed structural as well as individual stability in patterns of symptom reporting for nearly 30 years. That is, similar configurations of symptoms were found at both ages, and it was the same females who reported being either symptom free or reporting a high symptom load at both ages. At age 15 fewer early maturing females than expected by chance reported being symptom free, whereas more of the late maturing females than expected reported being symptom free. However, there were no effects of menarcheal timing on symptom reporting at age 43.

Entities:  

Mesh:

Year:  2004        PMID: 15181486      PMCID: PMC6878568          DOI: 10.1002/mpr.163

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  31 in total

1.  Determinants of perceived health status of medical outpatients.

Authors:  A J Barsky; P D Cleary; G L Klerman
Journal:  Soc Sci Med       Date:  1992-05       Impact factor: 4.634

2.  Pubertal timing and grade effects on adjustment.

Authors:  A C Petersen; L Crockett
Journal:  J Youth Adolesc       Date:  1985-06

3.  Personality, imaginative involvement, and self-reported somatic complaints: relevance to the concept of alexithymia.

Authors:  O Vassend
Journal:  Psychother Psychosom       Date:  1987       Impact factor: 17.659

4.  The impact of timing of puberty on psychosomatic symptoms among fourteen- to sixteen-year-old Finnish girls.

Authors:  H Aro; V Taipale
Journal:  Child Dev       Date:  1987-02

5.  The impact of cumulative change in early adolescence.

Authors:  R G Simmons; R Burgeson; S Carlton-Ford; D A Blyth
Journal:  Child Dev       Date:  1987-10

6.  A cross-cultural examination of the relationship between ages at menarche, marriage, and first birth.

Authors:  J R Udry; R L Cliquet
Journal:  Demography       Date:  1982-02

7.  Pubertal transition, stressful life events, and the emergence of gender differences in adolescent depressive symptoms.

Authors:  X Ge; R D Conger; G H Elder
Journal:  Dev Psychol       Date:  2001-05

8.  Adult physical health outcomes of adolescent girls with conduct disorder, depression, and anxiety.

Authors:  A M Bardone; T E Moffitt; A Caspi; N Dickson; W R Stanton; P A Silva
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-06       Impact factor: 8.829

9.  Longitudinal changes in risk variables underlying metabolic Syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study.

Authors:  M G Frontini; S R Srinivasan; G S Berenson
Journal:  Int J Obes Relat Metab Disord       Date:  2003-11

10.  Height, weight, body mass index and pubertal development reference values for children of Turkish origin in the Netherlands.

Authors:  A Miranda Fredriks; Stef van Buuren; Sara E R Jeurissen; Friedo W Dekker; S Pauline Verloove-Vanhorick; Jan Maarten Wit
Journal:  Eur J Pediatr       Date:  2003-08-26       Impact factor: 3.183

View more
  1 in total

Review 1.  A Systematic Literature Review of Factors Affecting the Timing of Menarche: The Potential for Climate Change to Impact Women's Health.

Authors:  Silvia P Canelón; Mary Regina Boland
Journal:  Int J Environ Res Public Health       Date:  2020-03-05       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.